40 /100
MEDIUM RISK
Score updated May 28, 2026

QNRX — Quoin Pharmaceuticals, Ltd. Dilution Risk Tracker

Track QNRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track QNRX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for QNRX.
🔔 Track QNRX — Get forecast alerts →

💹 Market Data

Market Cap$10.04M
Shares Outstanding2.01M
FloatN/A
Cash$14.04M
Debt$2.17M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 781.3K shares
#1 Ikarian Capital, LLC 211.5K shares
#2 Woodline Partners LP 79.6K shares
#3 Stonepine Capital Management, LLC 78.2K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest85.6K
Days to Cover2.9
% of FloatN/A
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Oct 14, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Mar 31, 2026
4 INSIDER TRANSACTION Feb 06, 2026
4 INSIDER TRANSACTION Feb 06, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track QNRX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking QNRX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AGCC AGH AIP AIRO
🔬 More Research for QNRX
📊 QNRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 QNRX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.